| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H22FN3O |
| Molar mass | 375.447 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5F-PCN (also known as5F-MN-21) is an azaindole-basedsynthetic cannabinoid that is presumed to be a potentagonist of theCB1 receptor and has been sold online as adesigner drug.[1][2] It is closely related toNNE1. Given the known metabolic liberation (and presence as an impurity) ofamantadine in the related compoundAPINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-PCN may release1-naphthylamine, a knowncarcinogen.
Sweden's public health agency suggested to classify 5F-PCN as hazardous substance on November 10, 2014.[3]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |